<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0355">
 <label>71</label>
 <mixed-citation publication-type="other" id="h0355">Regeneron and Sanofi Provide Update on KevzaraÂ® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients 
  <ext-link ext-link-type="uri" xlink:href="https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-provide-update-kevzarar-sarilumab-phase-3" id="ir100" xmlns:xlink="http://www.w3.org/1999/xlink">https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-provide-update-kevzarar-sarilumab-phase-3</ext-link>. Accessed 18 July 2020.
 </mixed-citation>
</ref>
